Ushbu ish iqtibos qilgan ishlar

100 ta ish

Ish: A comprehension of signaling pathways and drug resistance; an insight into the correlation between microRNAs and cancer

A view on drug resistance in cancer
Neil Vasan, José Baselga, David M. Hyman
Sharh maqola20197 iqtibos
ABI
Sarlavhasiz
Boshqa7 iqtibos
ABI
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole, Frank J. Slack
Sharh maqola20176 iqtibos
ABI
Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression
Elmira Roshani Asl, Mohammad Amini, Souzan Najafi +9
Sharh maqola20215 iqtibos
ABI
The role and mechanisms of action of microRNAs in cancer drug resistance
Wengong Si, Jiaying Shen, Huilin Zheng +1
Sharh maqola20194 iqtibos
ABI
miRNA: A Promising Therapeutic Target in Cancer
Amrutha Menon, Noraini Abd-Aziz, Kanwal Khalid +2
Sharh maqola20224 iqtibos
ABI
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
Khalid O. Alfarouk, C C Stock, Sophie Taylor +10
Maqola20153 iqtibos
ABI
Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients
Solmaz Khalighfard, Ali Mohammad Alizadeh, Shiva Irani +1
Maqola20183 iqtibos
ABI
Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma
Yingbin Huang, Guangyu Chen, Yang Wang +4
Maqola20182 iqtibos
ABI
MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling
Qingfeng Ni, Yan Zhang, Ran Tao +2
Maqola20212 iqtibos
ABI
miRNA-based biomarkers, therapies, and resistance in Cancer
Boxue He, Zhenyu Zhao, Qidong Cai +8
Sharh maqola20202 iqtibos
ABI
miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway
Sheng Liu, Qin Wang, Yin Liu +1
Maqola20192 iqtibos
ABI
The Roles of microRNAs in Cancer Multidrug Resistance
Lucia Pavlíková, Mário Šereš, Albert Breier +1
Sharh maqola20222 iqtibos
ABI
Drug Resistance in Cancer: An Overview
Genevieve Housman, Shannon Byler, Sarah Heerboth +4
Sharh maqola20142 iqtibos
ABI
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators
Elisabetta Vergani, Matteo Dugo, Mara Cossa +21
Maqola20202 iqtibos
ABI
MiR-181a upregulation is associated with epithelial-to-mesenchymal transition (EMT) and multidrug resistance (MDR) of ovarian cancer cells.
Li L, Xu Qh, Dong Yh +4
Maqola20162 iqtibos
ABI
Friend or foe: the role of microRNA in chemotherapy resistance
Haoran Li, Burton B. Yang
Sharh maqola20132 iqtibos
ABI
A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance
Wengong Si, Jiaying Shen, Chengyong Du +11
Maqola20172 iqtibos
ABI
The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies
Zhengjia Zhang, Qingcai Huang, Liuchunyang Yu +9
Sharh maqola20222 iqtibos
ABI
Recurrence after surgery in patients with NSCLC.
Hidetaka Uramoto, Fumihiro Tanaka
Sharh maqola20142 iqtibos
ABI
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Yunching Chen, Dong-Yu Gao, Leaf Huang
Sharh maqola20142 iqtibos
ABI
MiRNA Biogenesis and Regulation of Diseases: An Overview
Anchal Vishnoi, Sweta Rani
Sharh maqola20162 iqtibos
ABI
IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/β-catenin pathway
Ku‐Chung Chen, Peng-Hsu Chen, Kuo-Hao Ho +4
Maqola20192 iqtibos
ABI
MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro
Lisa Svartdal Normann, Miriam R. R. Aure, Suvi‐Katri Leivonen +5
Maqola20212 iqtibos
ABI
Emerging concepts of miRNA therapeutics: from cells to clinic
Caroline Diener, Andreas Keller, Eckart Meese
Sharh maqola20222 iqtibos
ABI